Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

312.40 +10.87 (+3.60%)
Streaming Delayed Price Updated: 1:49 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
2 S&P 500 Stocks with Solid Fundamentals and 1 We Find Risky
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Stocks
News headline image
BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
From BioStar Capital
Via Business Wire
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen ↗
Via Chartmill
News headline image
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
Stryker Corp (NYSE:SYK) Q1 Earnings Miss as Cyber Incident Recovery Weighs on Results ↗
Via Chartmill
Topics Earnings
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen with a Stellar 40.9% ROIC ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
From Stryker Corporation
Via GlobeNewswire
News headline image
Stryker declares an $0.88 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
News headline image
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and i... 
Via StockStory
News headline image
SYK Q1 Deep Dive: Cyber Incident Disrupts Operations, Management Reiterates Full-Year Outlook
Medical technology company Stryker (NYSE:SYK) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $6.02 billion. Its no... 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
News headline image
Stryker (SYK) Q1 2026 Earnings Transcript ↗
Stryker (SYK) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Stryker (NYSE:SYK) Misses Q1 CY2026 Sales Expectations
Medical technology company Stryker (NYSE:SYK) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $6.02 billion. Its no... 
Via StockStory
News headline image
Stryker reports first quarter 2026 operating results
From Stryker Corporation
Via GlobeNewswire
News headline image
Stryker (SYK) Q1 Earnings: What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting earnings this Thursday after the bell. Here’s what to look for. Stryker beat analysts’ revenu... 
Via StockStory
News headline image
2 Large-Cap Stocks Worth Investigating and 1 We Turn Down
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
Berger Montague PC Investigates Stryker Corporation’s Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
From Berger Montague
Via GlobeNewswire
News headline image
2 Profitable Stocks to Target This Week and 1 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance
As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9... 
Via MarketMinute
Topics Economy
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately... 
Via MarketMinute
Topics Economy
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting... 
Via MarketMinute
News headline image
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
From Stryker Corporation
Via GlobeNewswire
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
Over the last six months, Stryker shares have sunk to $342.00, producing a disappointing 7.6% loss - worse than the S&P 500’s 1.8% drop. This may have invest... 
Via StockStory
Topics Stocks Supply Chain
News headline image
This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market ↗
The company is a picture of financial stability. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.